Gorazd Drevensek Selected Research

LK-732

3/2005

Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gorazd Drevensek Research Topics

Disease

2	Ischemia 12/2010 - 04/2007
2	Reperfusion Injury 12/2010 - 04/2007
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2010
1	Hypoxia (Hypoxemia) 01/2009
1	Bone Resorption 10/2008
1	Ventricular Fibrillation 04/2007
1	Heart Arrest (Cardiac Arrest) 04/2007
1	Wounds and Injuries (Trauma) 04/2007
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2005
1	Thrombosis (Thrombus) 03/2005
1	Thrombophilia 03/2005

Drug/Important Bio-Agent (IBA)

1	Anthocyanins (Anthocyanin)IBA 12/2010
1	AntioxidantsIBA 12/2010
1	endothelium-dependent hyperpolarization factor (EDHF)IBA 01/2009
1	SolutionsIBA 01/2009
1	TBC 3214IBA 10/2008
1	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2007
1	Estradiol (Delestrogen)FDA LinkGeneric 04/2007
1	Testosterone (Sustanon)FDA Link 04/2007
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2007
1	argatroban (MPQA)FDA Link 03/2005
1	azaphenylalanineIBA 03/2005
1	LK-732IBA 03/2005
1	AntithrombinsIBA 03/2005
1	ProdrugsIBA 03/2005
1	Nadroparin (Nadroparin Calcium)IBA 03/2005
1	amidoximeIBA 03/2005